Literature DB >> 31228550

Biochemical characterization of RNA-guided ribonuclease activities for CRISPR-Cas9 systems.

Max J Gramelspacher1, Zhonggang Hou1, Yan Zhang2.   

Abstract

The majority of bacteria and archaea rely on CRISPR-Cas systems for RNA-guided, adaptive immunity against mobile genetic elements. The Cas9 family of type II CRISPR-associated DNA endonucleases generates programmable double strand breaks in the CRISPR-complementary DNA targets flanked by the PAM motif. Nowadays, CRISPR-Cas9 provides a set of powerful tools for precise genome manipulation in eukaryotes and prokaryotes. Recently, a few Cas9 orthologs have been reported to possess intrinsic CRISPR-guided, sequence-specific ribonuclease activities. These discoveries fundamentally expanded the targeting capability of CRISPR-Cas9 systems, and promise to provide new CRISPR tools to manipulate specific cellular RNA transcripts. Here we present a detailed method for the biochemical characterization of Cas9's RNA-targeting potential.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31228550      PMCID: PMC6923617          DOI: 10.1016/j.ymeth.2019.06.018

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  46 in total

1.  Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system.

Authors:  Bernd Zetsche; Jonathan S Gootenberg; Omar O Abudayyeh; Ian M Slaymaker; Kira S Makarova; Patrick Essletzbichler; Sara E Volz; Julia Joung; John van der Oost; Aviv Regev; Eugene V Koonin; Feng Zhang
Journal:  Cell       Date:  2015-09-25       Impact factor: 41.582

2.  Ribonuclease T1 generates circular RNA molecules from viroid-specific RNA transcripts by cleavage and intramolecular ligation.

Authors:  M Tsagris; M Tabler; H L Sänger
Journal:  Nucleic Acids Res       Date:  1991-04-11       Impact factor: 16.971

3.  Elimination of Toxic Microsatellite Repeat Expansion RNA by RNA-Targeting Cas9.

Authors:  Ranjan Batra; David A Nelles; Elaine Pirie; Steven M Blue; Ryan J Marina; Harrison Wang; Isaac A Chaim; James D Thomas; Nigel Zhang; Vu Nguyen; Stefan Aigner; Sebastian Markmiller; Guangbin Xia; Kevin D Corbett; Maurice S Swanson; Gene W Yeo
Journal:  Cell       Date:  2017-08-10       Impact factor: 41.582

4.  CRISPR RNA-Dependent Binding and Cleavage of Endogenous RNAs by the Campylobacter jejuni Cas9.

Authors:  Gaurav Dugar; Ryan T Leenay; Sara K Eisenbart; Thorsten Bischler; Belinda U Aul; Chase L Beisel; Cynthia M Sharma
Journal:  Mol Cell       Date:  2018-03-01       Impact factor: 17.970

Review 5.  Anti-CRISPR: discovery, mechanism and function.

Authors:  April Pawluk; Alan R Davidson; Karen L Maxwell
Journal:  Nat Rev Microbiol       Date:  2017-10-24       Impact factor: 60.633

6.  Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type IIC Anti-CRISPR Proteins.

Authors:  Yalan Zhu; Ang Gao; Qi Zhan; Yong Wang; Han Feng; Songqing Liu; Guangxia Gao; Alexander Serganov; Pu Gao
Journal:  Mol Cell       Date:  2019-03-05       Impact factor: 17.970

7.  Processing-independent CRISPR RNAs limit natural transformation in Neisseria meningitidis.

Authors:  Yan Zhang; Nadja Heidrich; Biju Joseph Ampattu; Carl W Gunderson; H Steven Seifert; Christoph Schoen; Jörg Vogel; Erik J Sontheimer
Journal:  Mol Cell       Date:  2013-05-23       Impact factor: 17.970

8.  RNA-dependent RNA targeting by CRISPR-Cas9.

Authors:  Steven C Strutt; Rachel M Torrez; Emine Kaya; Oscar A Negrete; Jennifer A Doudna
Journal:  Elife       Date:  2018-01-05       Impact factor: 8.140

Review 9.  Generation of 2',3'-Cyclic Phosphate-Containing RNAs as a Hidden Layer of the Transcriptome.

Authors:  Megumi Shigematsu; Takuya Kawamura; Yohei Kirino
Journal:  Front Genet       Date:  2018-11-27       Impact factor: 4.599

10.  NmeCas9 is an intrinsically high-fidelity genome-editing platform.

Authors:  Nadia Amrani; Xin D Gao; Pengpeng Liu; Alireza Edraki; Aamir Mir; Raed Ibraheim; Ankit Gupta; Kanae E Sasaki; Tong Wu; Paul D Donohoue; Alexander H Settle; Alexandra M Lied; Kyle McGovern; Chris K Fuller; Peter Cameron; Thomas G Fazzio; Lihua Julie Zhu; Scot A Wolfe; Erik J Sontheimer
Journal:  Genome Biol       Date:  2018-12-05       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.